Provided by Tiger Trade Technology Pte. Ltd.

Sutro Biopharma Inc

20.68
-0.4400-2.08%
Pre-market: 20.680.00000.00%07:36 EDT
Volume:598.20K
Turnover:12.39M
Market Cap:338.90M
PE:-0.80
High:21.63
Open:20.76
Low:20.18
Close:21.12
52wk High:26.54
52wk Low:5.23
Shares:16.39M
Float Shares:13.89M
Volume Ratio:4.00
T/O Rate:4.31%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-25.8759
EPS(LYR):-29.6061
ROE:-1810.01%
ROA:-25.80%
PB:-3.88
PE(LYR):-0.70

Loading ...

BRIEF-Sutro Biopharma Announces 1-For-10 Reverse Stock Split

Reuters
·
Dec 01, 2025

Sutro Biopharma Q3 Revenue USD 9.693 Million

Reuters
·
Nov 20, 2025

Sutro Biopharma Unveils STRO-227 as First Dual-Payload ADC Targeting PTK7

Reuters
·
Nov 12, 2025

Analysts Conflicted on These Healthcare Names: Madrigal Pharmaceuticals (MDGL), Doximity (DOCS) and Sutro Biopharma (STRO)

TIPRANKS
·
Nov 11, 2025

Sutro Biopharma Q3 revenue rises,  extends cash runway to mid-2027

Reuters
·
Nov 07, 2025

Sutro Biopharma Q3 EPS $(0.67) Misses $(0.41) Estimate, Sales $9.693M Beat $9.132M Estimate

Benzinga
·
Nov 07, 2025

Sutro Biopharma reports third quarter 2025 financial results with $167.6 million in cash and securities

Reuters
·
Nov 07, 2025

BRIEF-Sutro Biopharma Q3 Revenue USD 9.693 Million

Reuters
·
Nov 07, 2025

Sutro Biopharma Hosts Virtual R&D Day Highlighting ADC Pipeline

Reuters
·
Nov 06, 2025

Sutro Biopharma Showcases Next-Generation ADC Innovations at World ADC Conference

Reuters
·
Nov 03, 2025

Sutro Biopharma Chief Admin. Officer & GC David Pauling Reports Acquisition of Common Shares

Reuters
·
Oct 16, 2025

BRIEF-Sutro Biopharma says restructuring costs estimated at $4.1 million to $4.3 million - SEC filing

Reuters
·
Sep 30, 2025

BRIEF-Sutro Biopharma announces operational restructuring intended to extend cash runway

Reuters
·
Sep 30, 2025

Sutro Biopharma Inc - Restructuring Costs Estimated at $4.1 Mln to $4.3 Mln - SEC Filing

THOMSON REUTERS
·
Sep 30, 2025

Sutro Biopharma announces restructuring, workforce reduction of about 33%

TIPRANKS
·
Sep 30, 2025

Sutro Biopharma Inc - Announces Restructuring to Prioritize ADC Programs

THOMSON REUTERS
·
Sep 30, 2025

Sutro Biopharma Inc - Restructuring Expected to Extend Cash Runway Into Mid-2027

THOMSON REUTERS
·
Sep 30, 2025

Sutro Biopharma Inc - Restructuring to Result in Workforce Reduction of One-Third of Employees

THOMSON REUTERS
·
Sep 30, 2025

Sutro Biopharma Inc - on Track to Advance Stro-004 Into Clinic This Year, Data Expected 2026

THOMSON REUTERS
·
Sep 30, 2025

Sutro Biopharma Announces Major Restructuring, Cuts Workforce by One-Third to Extend Cash Runway Through 2027

Reuters
·
Sep 30, 2025